pages:
-
A Hyperspectral Approach to RPE Fluorophores in AMD
-
A Limited Purpose Cooperative Research and Developmental Agreement (LP-CRADA) Naval Medical Research Center
-
A Longitudinal Pilot Study Examining Neurocognitive Outcomes in Survivors of Acute Lymphoblastic Leukemia Before and After a Cognitive Remediation Program
-
A Low-Cost Cardiac Annunciator to Reduce Stillbirths and Neonatal Deaths
-
A Master Protocol to Test the Impact of Discontinuing Chronic Therapies in People With Cystic Fibrosis on Highly Effective CFTR Modulator Therapy (SIMPLIFY)
-
A Metabolomics Approach to Define a Novel Chemopreventive Pathway
-
A MIR-486/Dock3 Signaling Axis Modulates Dystrophin-Deficient Pathology
-
A Multi-arm, Multi-Center, Non-Randomized, Prospective, Clinical Study to Evaluate the Safety and Effectiveness of the NEXUS™ Aortic Arch Stent Graft System in Treating Thoracic Aortic Lesions Involving the Aortic Arch
-
A Multi-Center Group to Study Acute Liver Failure Grant Renewal RE: U01-DK 09-506
-
A Multi-Center Prospective Cohort Study of Sacral Fractures using Patient Based and Objective Outcomes
-
A Multi-Center Study of a New Method of Sweat Testing: The CF Quantum Sweat Test
-
A Multi-Center Trial to Evaluate Home Based Assessment Methods for Alzheimer's Disease Prevention Research in People Over 75 Years Old (ADC-030-HBA)
-
A Multi-Center Trial to Evaluate Home Based Assessment Methods for Alzheimer's Disease Prevention Research in People Over 75 Years Old (ADC-030-HBA)
-
A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glaltiramer Acetate to Either Agent Alone in Patients with Relapsing Remitting multiple Sclerosis (CombiRx-PhaseIII)
-
A Multi-Center, Double-Blind, Randomized, Placebo-Controlled Study of Weight-Reduction Diet Plus Acetazolamide vs. Diet Plus Placebo in Subjects with Idiopathic Intracranial Hypertension with Mild Vision Loss
-
A Multi-Center, Randomized, Controlled Trial of Cerebrospinal Fluid Drainage in Acute Spinal Cord Injury
-
A Multi-Center, Randomized, Double-Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Phase III Trial of the FLT3 Inhibitor Gilteritinib Administered as Maintenance Therapy Following Allogeneic Transplant for Patients with FLT3/ITD AML
-
A Multi-Component Behavioral Nutrition Intervention for Homebound Elderly
-
A Multi-Modal Neuro-Physiological Investigation of User-Centered Security
-
A Multi-site Trial of Specialist Palliative Care in CF
-
A Multi-Site, Double-Blind, Randomized, Placebo-Controlled, Crossover Study of Pregabalin (Lyrica, PGB) in the Treatment of Essential Tremor
-
A Multicenter Group to Study Acute Liver Failure
-
A Multicenter Phase III Randomized Trial Comparing Docetaxel in Combination with Doxorubicin and Cyclophosphamide (TAC) Versus Doxorubicin and Cyclophosphamide Followed by Docetaxel (AC--T) as Adjuvant Treatment of Operable Breast Cancer HER2Neu Negative Patients with Positive Axillary Lymph Nodes
-
A Multicenter Prospective Cohort Study of Sacral Fractures Using Patient Based and Objective Outcomes
-
A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients
-
A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults
-
A Multicenter, Adaptive, Randomized Controlled Platform Trial of the Safety and Efficacy of Antithrombotic Strategies in HospitalizedAdults with COVID-19
-
A Multicenter, Open-Label, Noncomparative Study for the International Maternal, Pediatric, Adolescent AIDS Clinical Trials Group to Evaluate the Safety, Pharmacokinetics, and Antiretroviral Activity of MK-0518 in HIV-1 Infected Children (Study)
-
A Multicenter, Single-Arm, Study Evaluating De Novo Once Every Two Week Darbepoetin alfa Dosing in Pediatric Subjects with Kidney Disease Receiving and Not Receiving Dialysis
pages:
